WASHINGTON—Even as Pfizer’s anti-coronavirus vaccine heads for approval in the U.S., and subsequent rollout, reports show it could have occurred sooner here, and that there could have been many more doses available. The reasons for the lag and the shortfall? GOP Oval Office occupant Donald Trump’s decisions, or lack of them. The delays and limited … Continue reading Vaccination starts in UK, concern grows over short supply in U.S.